Maternal, Child and Reproductive Health

PregVax: Plasmodium vivax Infection in Pregnancy

The PregVax project is a four-year collaborative project aimed at addressing knowledge gaps in pregnancy and vivax malaria

Approximately 25 million pregnant women exposed yearly to malaria live in areas where Plasmodium vivax is endemic.  While the effects of falciparum malaria in pregnancy have been well characterised and are responsible for considerable maternal and infant morbidity and mortality, surprisingly little is known about the impact of P. vivax infection during gestation.

Malaria in pregnancy was prioritised by the 7th Framework Program of the European Commission.  To fill the knowledge gaps of vivax malaria in pregnancy, the PregVax study carried out a cohort observational study in pregnant women in five P. vivax endemic countries, Brazil, Colombia, Guatemala, India, and Papua New Guinea, broadly representing most of the world's P. vivax infections.

Around ten thousand pregnant women were enrolled by the five sites in total at the time of routine antenatal care visits and followed-up at the health facility until delivery. 

Main Objectives

The main objective of the PregVax study is to describe the epidemiological and clinical features of P. vivax malaria in pregnancy.  The PregVax study will also determine if there are pregnancy-specific immune responses and characterize, genotypically and phenotypically, parasites of the placenta.

About Pregvax

Pregvax is a project of The Clinic Foundation.

It is funded by:
-Ministry of Economy and Competitivenes, Government of Spain 
-7th EU Framework Program (FP7).

It belongs to the Malaria in Pregnancy Consortium
 

Our Team

Principal Investigator

  • Clara Menéndez
    Clara Menéndez Research Professor, Director of the Maternal, Child and Reproductive Health Initiative and Programme

ISGlobal team

See More

Other projects

See Past Projects

MESA

The Malaria Eradication Scientific Alliance - MESA is dedicated to advancing the science of malaria eradication.

RTS,S Vaccine Immunology Study

Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial

MiPMon

Pregnant women as a sentinel group for malaria surveillance in an era of changing malaria transmission

AlphaGal

Exploration of the singularities of the sugar nucleotide metabolism and description of novel glycosylation pathways in the malaria parasite

TIPTOP

Transforming IPT for optimal pregnancy

NANOpheles

Development of nanovectors for the targeted delivery in Anopheles mosquitoes of agents blocking transmission of Plasmodium parasites

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

GenMoz

P. falciparum genomic intelligence in Mozambique

ADAM

Malaria mass and focal drug administration to advance malaria elimination in Mozambique: accelerating programmatic implementation and policy translation

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

ECO

Enhanced and equitable coverage of COVID-19 testing and treatment in Bolivia and Paraguay

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

CaDMIA-plus

Continued validation of the minimally invasive autopsy for the investigation of the causes of death in infants, and establishment of a research and training center to study causes of death

METRO

Measuring community prevalence among HIV exposed children in rural Southern Mozambique

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

MIBio

Identification of Prematurity and Pre-Eclampsia as Causes of Mortality

STREESCO

Strengthening Epidemiological Surveillance in Benin and Burkina Faso for an Effective Response to COVID-19

MA-CoV

Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations

IPERVAC-SL

Impact of perceptions of COVID-19 vaccines on health-seeking behaviours in Sierra Leone

RESPIRE

Respiratory syncytial virus (RSV) in African pregnant women and children

VITAL

Towards preparedness for new maternal vaccinations: Understanding barriers and facilitators to maternal vaccine acceptance